Midwest Professional Planners Ltd (MPPL)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.55M | Sell |
40,601
-727
| -2% | -$58.2K | 0.6% | 58 |
|
|
2025
Q4 | $3.94M | Sell |
41,328
-5,064
| -11% | -$496K | 0.93% | 33 |
|
|
2025
Q3 | $4.53M | Sell |
46,392
-100
| -0.2% | -$10.4K | 1.11% | 26 |
|
|
2025
Q2 | $4.99M | Buy |
46,492
+653
| +1% | +$66.1K | 1.31% | 20 |
|
|
2025
Q1 | $4.62M | Sell |
45,839
-724
| -2% | -$72.9K | 1.44% | 15 |
|
|
2024
Q4 | $4.16M | Sell |
46,563
-1,067
| -2% | -$93.9K | 1.24% | 18 |
|
|
2024
Q3 | $3.99M | Buy |
47,630
+2,400
| +5% | +$189K | 1.22% | 19 |
|
|
2024
Q2 | $3.48M | Buy |
45,230
+496
| +1% | +$36.3K | 1.16% | 19 |
|
|
2024
Q1 | $3.06M | Sell |
44,734
-2,914
| -6% | -$187K | 1.07% | 23 |
|
|
2023
Q4 | $2.75M | Buy |
47,648
+2,292
| +5% | +$122K | 1.1% | 24 |
|
|
2023
Q3 | $2.39M | Buy |
45,356
+3,265
| +8% | +$171K | 1.08% | 25 |
|
|
2023
Q2 | $2.28M | Buy |
42,091
+4,301
| +11% | +$225K | 1% | 28 |
|
|
2023
Q1 | $1.89M | Buy |
37,790
+1,763
| +5% | +$83.1K | 0.92% | 32 |
|
|
2022
Q4 | $1.67M | Buy |
36,027
+2,274
| +7% | +$98.5K | 0.92% | 37 |
|
|
2022
Q3 | $1.31M | Buy |
33,753
+1,761
| +6% | +$70.6K | 0.78% | 38 |
|
|
2022
Q2 | $1.19M | Buy |
31,992
+1,466
| +5% | +$59.7K | 0.67% | 41 |
|
|
2022
Q1 | $1.35M | Buy |
30,526
+1,609
| +6% | +$69.7K | 0.67% | 41 |
|
|
2021
Q4 | $1.23M | Buy |
28,917
+462
| +2% | +$19.4K | 0.6% | 53 |
|
|
2021
Q3 | $1.24M | Buy |
28,455
+250
| +0.9% | +$11.1K | 0.66% | 50 |
|
|
2021
Q2 | $1.21M | Buy |
28,205
+2,779
| +11% | +$117K | 0.63% | 48 |
|
|
2021
Q1 | $830K | Sell |
25,426
-2,739
| -10% | -$104K | 0.82% | 36 |
|
|
2020
Q4 | $1.01M | Buy |
28,165
+481
| +2% | +$17.3K | 0.62% | 47 |
|
|
2020
Q3 | $1.06M | Buy |
27,684
+1,518
| +6% | +$58.5K | 0.74% | 38 |
|
|
2020
Q2 | $919K | Buy |
26,166
+740
| +3% | +$26.6K | 0.72% | 41 |
|
|
2020
Q1 | $830K | Buy |
25,426
+317
| +1% | +$12.4K | 0.82% | 37 |
|
|
2019
Q4 | $1.14M | Buy |
25,109
+225
| +0.9% | +$9.41K | 0.93% | 29 |
|
|
2019
Q3 | $1.01M | Sell |
24,884
-130
| -0.5% | -$5.51K | 0.91% | 30 |
|
|
2019
Q2 | $1.07M | Buy |
25,014
+400
| +2% | +$15.4K | 1% | 32 |
|
|
2019
Q1 | $945K | Buy |
24,614
+40
| +0.2% | +$1.53K | 0.91% | 28 |
|
|
2018
Q4 | $868K | Sell |
24,574
-258
| -1% | -$9.36K | 0.93% | 26 |
|
|
2018
Q3 | $956K | Buy |
24,832
+981
| +4% | +$34.3K | 0.88% | 27 |
|
|
2018
Q2 | $780K | Buy |
23,851
+445
| +2% | +$13.4K | 0.7% | 27 |
|
|
2018
Q1 | $639K | Buy |
23,406
+871
| +4% | +$23.7K | 0.58% | 40 |
|
|
2017
Q4 | $559K | Buy |
+22,535
| New | +$622K | 0.51% | 49 |
|
Other funds holding BSX
VCM
VPM
Midwest Professional Planners Ltd (MPPL)'s BSX Position: Q1 2026 in Review
Midwest Professional Planners Ltd (MPPL) reduced its Boston Scientific (BSX) stake by 1.8% in Q1 2026, selling an estimated $58.2K and leaving 40,601 shares worth $2.55M. The position accounts for 0.6% of the portfolio, ranked #58.
Midwest Professional Planners Ltd (MPPL) first reported a position in BSX in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.99M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Midwest Professional Planners Ltd (MPPL) held 40,601 shares of Boston Scientific worth $2.55M as of Q1 2026.
- Midwest Professional Planners Ltd (MPPL) sold 727 Boston Scientific shares in Q1 2026, an estimated $58.2K.
- Boston Scientific made up 0.6% of Midwest Professional Planners Ltd (MPPL)'s portfolio in Q1 2026, its #58 holding.
- Midwest Professional Planners Ltd (MPPL) first reported a position in Boston Scientific in Q4 2017 and has held it in 34 quarters since.
- Midwest Professional Planners Ltd (MPPL)'s Boston Scientific position peaked at $4.99M in Q2 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q1 2026, filed 5 May 2026.